Atlas Trials

Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT02971410 · WITHDRAWN

Trial details

NCT number
NCT02971410
Sponsor
Wake Forest University Health Sciences
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Start date
2017-04-01
Primary completion
2021-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.